Psychoneurobiology Research and Personalized Treatment of Schizophrenia

doi:10.3390/books978-3-0365-2858-8

Download Url(s)

https://mdpi.com/books/pdfview/book/4865

Contributor(s)

Sumiyoshi, Tomiki (editor)

Language

English

Show full item record

Abstract

Schizophrenia is a common disease characterized by psychotic symptoms (e.g., delusion, hallucinations, blunted affect) and disturbances of cognitive function (e.g., memory, abstraction, attention). If not treated properly, patients may experience serious consequences in terms of social function. Much endeavor in several disciplines of medical science has been made to overcome the paucity of effective treatments for unmet needs, including cognitive impairment associated with schizophrenia.This Book, contributed by experts from various regions of the globe, provides up-to-date information to facilitate the development of personal therapeutics for this enigmatic illness.

URI

https://directory.doabooks.org/handle/20.500.12854/78772

Keywords

first-episode psychosis; metacognitive training; cognitive insight; sessions; experiment; magnetic resonance imaging; schizophrenia; schizotypal disorder; gyrification; superior temporal gyrus; neurodevelopment; cannabis; proteomics; olfactory neuroepithelium; metabolism; RNA; ZNF326; MTREX; antipsychotics; body mass index; weight gain; metabolic syndrome; serotonin; genes; pharmacogenetics; mental disorders; developmental disorders; social cognition; social function; facial expression recognition; test battery; quality of life; systematic review; needs survey; neuromodulation; transcranial direct current stimulation (tDCS); superior temporal sulcus; P300; event-related potentials; clinical high-risk; psychosis; at risk mental state; cognition; latency; microglia; synaptic pruning; complement; CX3CR1; medication; diagnosis; piccolo; presynaptic cytomatrix protein; medial prefrontal cortex; dorsal striatum; optogenetics; social functioning; n/a